Intra-Cellular Therapies, Inc. (ITCI): Among the Most Promising Mid-Cap Stocks According to Hedge Funds

The article discusses the top mid-cap stocks favored by hedge funds, focusing on Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), ranking 8th.